PSMC2 and acute myeloid leukemia: However, AML patients with high expression of <i>PSMC2</i>-5 had worse outcomes.<h4>Discussion</h4>Altogether, our data suggest that components of the 19S proteasome could serve as prognostic biomarkers and novel therapeutic targets in AML and several other human malignancies.